Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double‐blind, placebo‐controlled, 24‐week trial (GetGoal‐M‐Asia)

Yu Pan, Chang; Han, Ping; Liu, Xiaoming; Yan, Shengli; Feng, Ping; Zhou, Zhiguang; Lv, Xiaofeng; Tian, Hui; Jin Kui, Yang; Su, Benli; Shang, Shuhua; Niemoeller, Elisabeth

doi:10.1002/dmrr.2541

Public

Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double‐blind, placebo‐controlled, 24‐week trial (GetGoal‐M‐Asia)

Published in Diabetes/Metabolism Research and Reviews • Mar 18, 2014

Authors:

Chang Yu Pan

Ping Han

Xiaoming Liu

Abstract

BACKGROUND: This study assessed the efficacy and safety of the once-daily glucagon-like peptide-1 receptor agonist, lixisenatide, in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin ± sulfonylurea. METHODS: In this 24-week, double-blind, placebo-controlled, multinati...

Subject

Lixisenatide

Placebo

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!